Arrowhead Research reported $-62379000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Anika Therapeutics ANIK:US $ 6.33M 8.56M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Arrowhead Research ARWR:US $ -62379000 32.51M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Cerulean Pharma CERU:US $ -12.66M 3.51M
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Ligand Pharmaceuticals LGND:US $ 28.43M 29.92M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Moderna Inc MRNA:US 3.63B 497M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Novartis NOVN:VX SF 4837M 65M
Opko Health OPK:US $ 25.33M 0.84M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Spectrum Pharmaceuticals SPPI:US $ -33.02M 10.98M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
Xencor XNCR:US $ -39.31M 50.15M
YTE INCY:US $ 262.16M 92.39M